nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—ABCG2—primary biliary cirrhosis	0.51	1	CbGaD
Dabrafenib—CYP2C8—Colchicine—primary biliary cirrhosis	0.0709	0.347	CbGbCtD
Dabrafenib—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0569	0.278	CbGbCtD
Dabrafenib—ABCB1—Colchicine—primary biliary cirrhosis	0.048	0.235	CbGbCtD
Dabrafenib—CYP3A4—Colchicine—primary biliary cirrhosis	0.0288	0.141	CbGbCtD
Dabrafenib—Skin papilloma—Ursodeoxycholic acid—primary biliary cirrhosis	0.00515	0.0303	CcSEcCtD
Dabrafenib—Skin papilloma—Chenodeoxycholic acid—primary biliary cirrhosis	0.00515	0.0303	CcSEcCtD
Dabrafenib—Cardiomyopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00328	0.0193	CcSEcCtD
Dabrafenib—Cardiomyopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00328	0.0193	CcSEcCtD
Dabrafenib—Polyp—Ursodeoxycholic acid—primary biliary cirrhosis	0.00276	0.0162	CcSEcCtD
Dabrafenib—Polyp—Chenodeoxycholic acid—primary biliary cirrhosis	0.00276	0.0162	CcSEcCtD
Dabrafenib—Cyst—Ursodeoxycholic acid—primary biliary cirrhosis	0.00251	0.0148	CcSEcCtD
Dabrafenib—Cyst—Chenodeoxycholic acid—primary biliary cirrhosis	0.00251	0.0148	CcSEcCtD
Dabrafenib—Gamma-glutamyltransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00204	0.012	CcSEcCtD
Dabrafenib—Gamma-glutamyltransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00204	0.012	CcSEcCtD
Dabrafenib—Creatinine increased—Colchicine—primary biliary cirrhosis	0.00196	0.0115	CcSEcCtD
Dabrafenib—Bone disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00186	0.0109	CcSEcCtD
Dabrafenib—Bone disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00186	0.0109	CcSEcCtD
Dabrafenib—Cellulitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00185	0.0108	CcSEcCtD
Dabrafenib—Cellulitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00185	0.0108	CcSEcCtD
Dabrafenib—Creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00176	0.0104	CcSEcCtD
Dabrafenib—Creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00176	0.0104	CcSEcCtD
Dabrafenib—Rash maculo-papular—Colchicine—primary biliary cirrhosis	0.0017	0.00998	CcSEcCtD
Dabrafenib—Influenza like illness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00958	CcSEcCtD
Dabrafenib—Influenza like illness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00958	CcSEcCtD
Dabrafenib—Neoplasm—Chenodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00892	CcSEcCtD
Dabrafenib—Neoplasm—Ursodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00892	CcSEcCtD
Dabrafenib—Blood alkaline phosphatase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00823	CcSEcCtD
Dabrafenib—Blood alkaline phosphatase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00823	CcSEcCtD
Dabrafenib—Cardiac failure congestive—Ursodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00789	CcSEcCtD
Dabrafenib—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00789	CcSEcCtD
Dabrafenib—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.00127	0.00746	CcSEcCtD
Dabrafenib—Dehydration—Colchicine—primary biliary cirrhosis	0.00126	0.00741	CcSEcCtD
Dabrafenib—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00122	0.00717	CcSEcCtD
Dabrafenib—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.0012	0.00703	CcSEcCtD
Dabrafenib—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00671	CcSEcCtD
Dabrafenib—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00671	CcSEcCtD
Dabrafenib—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00666	CcSEcCtD
Dabrafenib—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00666	CcSEcCtD
Dabrafenib—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.00112	0.0066	CcSEcCtD
Dabrafenib—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00654	CcSEcCtD
Dabrafenib—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00654	CcSEcCtD
Dabrafenib—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00645	CcSEcCtD
Dabrafenib—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00645	CcSEcCtD
Dabrafenib—Neutropenia—Colchicine—primary biliary cirrhosis	0.0011	0.00644	CcSEcCtD
Dabrafenib—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00631	CcSEcCtD
Dabrafenib—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00631	CcSEcCtD
Dabrafenib—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00607	CcSEcCtD
Dabrafenib—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00607	CcSEcCtD
Dabrafenib—Stomatitis—Colchicine—primary biliary cirrhosis	0.00102	0.00598	CcSEcCtD
Dabrafenib—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00593	CcSEcCtD
Dabrafenib—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00593	CcSEcCtD
Dabrafenib—Haematuria—Colchicine—primary biliary cirrhosis	0.000997	0.00585	CcSEcCtD
Dabrafenib—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000939	0.00552	CcSEcCtD
Dabrafenib—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000939	0.00552	CcSEcCtD
Dabrafenib—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000939	0.00552	CcSEcCtD
Dabrafenib—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000939	0.00552	CcSEcCtD
Dabrafenib—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000923	0.00542	CcSEcCtD
Dabrafenib—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000923	0.00542	CcSEcCtD
Dabrafenib—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000913	0.00536	CcSEcCtD
Dabrafenib—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000913	0.00536	CcSEcCtD
Dabrafenib—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000895	0.00526	CcSEcCtD
Dabrafenib—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000895	0.00526	CcSEcCtD
Dabrafenib—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000886	0.0052	CcSEcCtD
Dabrafenib—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000886	0.0052	CcSEcCtD
Dabrafenib—Eye disorder—Colchicine—primary biliary cirrhosis	0.000877	0.00515	CcSEcCtD
Dabrafenib—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000847	0.00498	CcSEcCtD
Dabrafenib—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000847	0.00498	CcSEcCtD
Dabrafenib—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000846	0.00497	CcSEcCtD
Dabrafenib—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000843	0.00495	CcSEcCtD
Dabrafenib—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000843	0.00495	CcSEcCtD
Dabrafenib—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000833	0.00489	CcSEcCtD
Dabrafenib—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000833	0.00489	CcSEcCtD
Dabrafenib—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000831	0.00488	CcSEcCtD
Dabrafenib—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000831	0.00488	CcSEcCtD
Dabrafenib—Alopecia—Colchicine—primary biliary cirrhosis	0.000829	0.00487	CcSEcCtD
Dabrafenib—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000829	0.00487	CcSEcCtD
Dabrafenib—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000829	0.00487	CcSEcCtD
Dabrafenib—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000826	0.00485	CcSEcCtD
Dabrafenib—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000826	0.00485	CcSEcCtD
Dabrafenib—Malnutrition—Colchicine—primary biliary cirrhosis	0.000817	0.0048	CcSEcCtD
Dabrafenib—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000788	0.00463	CcSEcCtD
Dabrafenib—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000788	0.00463	CcSEcCtD
Dabrafenib—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000785	0.00461	CcSEcCtD
Dabrafenib—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000765	0.00449	CcSEcCtD
Dabrafenib—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000765	0.00449	CcSEcCtD
Dabrafenib—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000762	0.00447	CcSEcCtD
Dabrafenib—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000762	0.00447	CcSEcCtD
Dabrafenib—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00076	0.00446	CcSEcCtD
Dabrafenib—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00076	0.00446	CcSEcCtD
Dabrafenib—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000757	0.00444	CcSEcCtD
Dabrafenib—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000757	0.00444	CcSEcCtD
Dabrafenib—Anaemia—Colchicine—primary biliary cirrhosis	0.000755	0.00443	CcSEcCtD
Dabrafenib—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000753	0.00442	CcSEcCtD
Dabrafenib—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000753	0.00442	CcSEcCtD
Dabrafenib—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000745	0.00438	CcSEcCtD
Dabrafenib—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000745	0.00438	CcSEcCtD
Dabrafenib—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000734	0.00431	CcSEcCtD
Dabrafenib—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000734	0.00431	CcSEcCtD
Dabrafenib—Leukopenia—Colchicine—primary biliary cirrhosis	0.000731	0.00429	CcSEcCtD
Dabrafenib—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00071	0.00417	CcSEcCtD
Dabrafenib—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00071	0.00417	CcSEcCtD
Dabrafenib—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000706	0.00414	CcSEcCtD
Dabrafenib—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000706	0.00414	CcSEcCtD
Dabrafenib—Arthralgia—Colchicine—primary biliary cirrhosis	0.000695	0.00408	CcSEcCtD
Dabrafenib—Myalgia—Colchicine—primary biliary cirrhosis	0.000695	0.00408	CcSEcCtD
Dabrafenib—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000678	0.00398	CcSEcCtD
Dabrafenib—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000678	0.00398	CcSEcCtD
Dabrafenib—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000657	0.00386	CcSEcCtD
Dabrafenib—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000657	0.00386	CcSEcCtD
Dabrafenib—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000654	0.00384	CcSEcCtD
Dabrafenib—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000653	0.00383	CcSEcCtD
Dabrafenib—Skin disorder—Colchicine—primary biliary cirrhosis	0.000648	0.0038	CcSEcCtD
Dabrafenib—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00064	0.00376	CcSEcCtD
Dabrafenib—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00064	0.00376	CcSEcCtD
Dabrafenib—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000634	0.00372	CcSEcCtD
Dabrafenib—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000634	0.00372	CcSEcCtD
Dabrafenib—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000625	0.00367	CcSEcCtD
Dabrafenib—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000625	0.00367	CcSEcCtD
Dabrafenib—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000625	0.00367	CcSEcCtD
Dabrafenib—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000625	0.00367	CcSEcCtD
Dabrafenib—Hypotension—Colchicine—primary biliary cirrhosis	0.000623	0.00366	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000621	0.00364	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000621	0.00364	CcSEcCtD
Dabrafenib—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000611	0.00359	CcSEcCtD
Dabrafenib—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000611	0.00359	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000607	0.00357	CcSEcCtD
Dabrafenib—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000599	0.00352	CcSEcCtD
Dabrafenib—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000599	0.00352	CcSEcCtD
Dabrafenib—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000595	0.0035	CcSEcCtD
Dabrafenib—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000595	0.0035	CcSEcCtD
Dabrafenib—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000587	0.00345	CcSEcCtD
Dabrafenib—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000587	0.00345	CcSEcCtD
Dabrafenib—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000586	0.00344	CcSEcCtD
Dabrafenib—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000586	0.00344	CcSEcCtD
Dabrafenib—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000582	0.00342	CcSEcCtD
Dabrafenib—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000582	0.00342	CcSEcCtD
Dabrafenib—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00058	0.0034	CcSEcCtD
Dabrafenib—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000579	0.0034	CcSEcCtD
Dabrafenib—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000579	0.0034	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000576	0.00338	CcSEcCtD
Dabrafenib—Fatigue—Colchicine—primary biliary cirrhosis	0.000575	0.00338	CcSEcCtD
Dabrafenib—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00056	0.00329	CcSEcCtD
Dabrafenib—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00056	0.00329	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000546	0.00321	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000546	0.00321	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000545	0.0032	CcSEcCtD
Dabrafenib—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000542	0.00318	CcSEcCtD
Dabrafenib—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000542	0.00318	CcSEcCtD
Dabrafenib—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000527	0.0031	CcSEcCtD
Dabrafenib—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000521	0.00306	CcSEcCtD
Dabrafenib—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000521	0.00306	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000517	0.00304	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000517	0.00304	CcSEcCtD
Dabrafenib—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000516	0.00303	CcSEcCtD
Dabrafenib—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000516	0.00303	CcSEcCtD
Dabrafenib—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000512	0.00301	CcSEcCtD
Dabrafenib—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000512	0.00301	CcSEcCtD
Dabrafenib—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000491	0.00289	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00288	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00288	CcSEcCtD
Dabrafenib—Asthenia—Colchicine—primary biliary cirrhosis	0.000478	0.00281	CcSEcCtD
Dabrafenib—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000474	0.00278	CcSEcCtD
Dabrafenib—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000474	0.00278	CcSEcCtD
Dabrafenib—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000474	0.00278	CcSEcCtD
Dabrafenib—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000474	0.00278	CcSEcCtD
Dabrafenib—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000456	0.00268	CcSEcCtD
Dabrafenib—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000441	0.00259	CcSEcCtD
Dabrafenib—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000441	0.00259	CcSEcCtD
Dabrafenib—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00043	0.00252	CcSEcCtD
Dabrafenib—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00043	0.00252	CcSEcCtD
Dabrafenib—Vomiting—Colchicine—primary biliary cirrhosis	0.000424	0.00249	CcSEcCtD
Dabrafenib—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00249	CcSEcCtD
Dabrafenib—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00249	CcSEcCtD
Dabrafenib—Rash—Colchicine—primary biliary cirrhosis	0.00042	0.00247	CcSEcCtD
Dabrafenib—Dermatitis—Colchicine—primary biliary cirrhosis	0.00042	0.00247	CcSEcCtD
Dabrafenib—Headache—Colchicine—primary biliary cirrhosis	0.000418	0.00245	CcSEcCtD
Dabrafenib—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00041	0.00241	CcSEcCtD
Dabrafenib—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00041	0.00241	CcSEcCtD
Dabrafenib—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000396	0.00233	CcSEcCtD
Dabrafenib—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000396	0.00233	CcSEcCtD
Dabrafenib—Nausea—Colchicine—primary biliary cirrhosis	0.000396	0.00233	CcSEcCtD
Dabrafenib—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000381	0.00224	CcSEcCtD
Dabrafenib—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000381	0.00224	CcSEcCtD
Dabrafenib—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00222	CcSEcCtD
Dabrafenib—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00222	CcSEcCtD
Dabrafenib—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000377	0.00222	CcSEcCtD
Dabrafenib—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000377	0.00222	CcSEcCtD
Dabrafenib—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000375	0.0022	CcSEcCtD
Dabrafenib—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000375	0.0022	CcSEcCtD
Dabrafenib—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000356	0.00209	CcSEcCtD
Dabrafenib—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000356	0.00209	CcSEcCtD
Dabrafenib—BRAF—MAPK Signaling Pathway—NFKB1—primary biliary cirrhosis	7.68e-05	0.000664	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—CD80—primary biliary cirrhosis	7.67e-05	0.000664	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—CD80—primary biliary cirrhosis	7.62e-05	0.00066	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—CD80—primary biliary cirrhosis	7.61e-05	0.000658	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—CD80—primary biliary cirrhosis	7.57e-05	0.000655	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Interleukins—NFKB1—primary biliary cirrhosis	7.56e-05	0.000654	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	7.55e-05	0.000653	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ABCB4—primary biliary cirrhosis	7.54e-05	0.000653	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—DLAT—primary biliary cirrhosis	7.54e-05	0.000653	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—TYK2—primary biliary cirrhosis	7.5e-05	0.000649	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	7.48e-05	0.000647	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	7.42e-05	0.000642	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—TYK2—primary biliary cirrhosis	7.38e-05	0.000639	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—TYK2—primary biliary cirrhosis	7.34e-05	0.000635	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	7.15e-05	0.000619	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	7.11e-05	0.000615	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—TYK2—primary biliary cirrhosis	7.05e-05	0.00061	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—TYK2—primary biliary cirrhosis	7.02e-05	0.000607	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—GGT1—primary biliary cirrhosis	6.98e-05	0.000604	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—TYK2—primary biliary cirrhosis	6.98e-05	0.000604	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	6.96e-05	0.000602	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—TYK2—primary biliary cirrhosis	6.95e-05	0.000601	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	6.95e-05	0.000601	CbGpPWpGaD
Dabrafenib—SLCO1B3—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	6.91e-05	0.000598	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	6.9e-05	0.000597	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	6.87e-05	0.000594	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—CD80—primary biliary cirrhosis	6.86e-05	0.000593	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD40LG—primary biliary cirrhosis	6.81e-05	0.000589	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	6.65e-05	0.000575	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	6.58e-05	0.00057	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—MMP9—primary biliary cirrhosis	6.55e-05	0.000567	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	6.54e-05	0.000566	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—TYK2—primary biliary cirrhosis	6.54e-05	0.000566	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—TYK2—primary biliary cirrhosis	6.54e-05	0.000566	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—TYK2—primary biliary cirrhosis	6.54e-05	0.000566	CbGpPWpGaD
Dabrafenib—BRAF—Disease—ELMO1—primary biliary cirrhosis	6.51e-05	0.000564	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	6.5e-05	0.000563	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—TYK2—primary biliary cirrhosis	6.48e-05	0.000561	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—NFKB1—primary biliary cirrhosis	6.48e-05	0.000561	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD3D—primary biliary cirrhosis	6.44e-05	0.000557	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—TYK2—primary biliary cirrhosis	6.44e-05	0.000557	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—TYK2—primary biliary cirrhosis	6.42e-05	0.000556	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	6.42e-05	0.000555	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—TYK2—primary biliary cirrhosis	6.39e-05	0.000553	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	6.36e-05	0.00055	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	6.18e-05	0.000535	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—MMP9—primary biliary cirrhosis	6.18e-05	0.000534	CbGpPWpGaD
Dabrafenib—SLC22A8—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	6.12e-05	0.000529	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—OGDH—primary biliary cirrhosis	6.05e-05	0.000523	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	6.05e-05	0.000523	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	6.03e-05	0.000521	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	6.02e-05	0.000521	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—NFKB1—primary biliary cirrhosis	6.01e-05	0.00052	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL7R—primary biliary cirrhosis	5.92e-05	0.000512	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—TYK2—primary biliary cirrhosis	5.79e-05	0.000501	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	5.77e-05	0.000499	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—NFKB1—primary biliary cirrhosis	5.72e-05	0.000495	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CDH5—primary biliary cirrhosis	5.64e-05	0.000488	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—ALB—primary biliary cirrhosis	5.62e-05	0.000486	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—MAP3K14—primary biliary cirrhosis	5.61e-05	0.000485	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—OGDH—primary biliary cirrhosis	5.6e-05	0.000485	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	5.6e-05	0.000484	CbGpPWpGaD
Dabrafenib—BRAF—Disease—NUP210—primary biliary cirrhosis	5.58e-05	0.000483	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	5.46e-05	0.000472	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCR5—primary biliary cirrhosis	5.43e-05	0.00047	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PDHX—primary biliary cirrhosis	5.39e-05	0.000467	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—NFKB1—primary biliary cirrhosis	5.31e-05	0.00046	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—CD80—primary biliary cirrhosis	5.28e-05	0.000456	CbGpPWpGaD
Dabrafenib—SLC22A6—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	5.11e-05	0.000442	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—NFKB1—primary biliary cirrhosis	5.09e-05	0.000441	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—DLAT—primary biliary cirrhosis	5.07e-05	0.000439	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ABCB4—primary biliary cirrhosis	5.07e-05	0.000439	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD80—primary biliary cirrhosis	5.07e-05	0.000438	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—NFKB1—primary biliary cirrhosis	5.02e-05	0.000434	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CTLA4—primary biliary cirrhosis	4.99e-05	0.000432	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PDHX—primary biliary cirrhosis	4.99e-05	0.000432	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—PPARGC1A—primary biliary cirrhosis	4.94e-05	0.000427	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCL9—primary biliary cirrhosis	4.93e-05	0.000426	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ELMO1—primary biliary cirrhosis	4.88e-05	0.000422	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—TAB1—primary biliary cirrhosis	4.87e-05	0.000421	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	4.82e-05	0.000417	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LBR—primary biliary cirrhosis	4.81e-05	0.000416	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	4.79e-05	0.000415	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD79A—primary biliary cirrhosis	4.76e-05	0.000412	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—DLAT—primary biliary cirrhosis	4.69e-05	0.000406	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ABCB4—primary biliary cirrhosis	4.69e-05	0.000406	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	4.67e-05	0.000404	CbGpPWpGaD
Dabrafenib—SLCO1B1—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	4.65e-05	0.000402	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ELMO1—primary biliary cirrhosis	4.56e-05	0.000395	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—NUP210—primary biliary cirrhosis	4.53e-05	0.000392	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—TYK2—primary biliary cirrhosis	4.53e-05	0.000392	CbGpPWpGaD
Dabrafenib—RAF1—Disease—ELMO1—primary biliary cirrhosis	4.51e-05	0.00039	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—TYK2—primary biliary cirrhosis	4.45e-05	0.000385	CbGpPWpGaD
Dabrafenib—BRAF—Disease—GOT2—primary biliary cirrhosis	4.41e-05	0.000382	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—TYK2—primary biliary cirrhosis	4.28e-05	0.00037	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—MMP2—primary biliary cirrhosis	4.22e-05	0.000365	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ABCG2—primary biliary cirrhosis	4.22e-05	0.000365	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LBR—primary biliary cirrhosis	4.19e-05	0.000362	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—NUP210—primary biliary cirrhosis	4.18e-05	0.000362	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	4.15e-05	0.000359	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—TYK2—primary biliary cirrhosis	4.03e-05	0.000349	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CDH5—primary biliary cirrhosis	3.9e-05	0.000338	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD40LG—primary biliary cirrhosis	3.88e-05	0.000336	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NUP210—primary biliary cirrhosis	3.86e-05	0.000334	CbGpPWpGaD
Dabrafenib—BRAF—Disease—GOT1—primary biliary cirrhosis	3.81e-05	0.00033	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCR5—primary biliary cirrhosis	3.76e-05	0.000325	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	3.75e-05	0.000324	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	3.71e-05	0.000321	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	3.7e-05	0.00032	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CTGF—primary biliary cirrhosis	3.62e-05	0.000313	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GOT2—primary biliary cirrhosis	3.58e-05	0.00031	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	3.56e-05	0.000308	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—NFKB1—primary biliary cirrhosis	3.53e-05	0.000305	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	3.51e-05	0.000304	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—OGDH—primary biliary cirrhosis	3.48e-05	0.000301	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—NFKB1—primary biliary cirrhosis	3.47e-05	0.0003	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—NOS2—primary biliary cirrhosis	3.44e-05	0.000298	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCL9—primary biliary cirrhosis	3.41e-05	0.000295	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—NFKB1—primary biliary cirrhosis	3.33e-05	0.000288	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	3.26e-05	0.000282	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.24e-05	0.00028	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—MMP9—primary biliary cirrhosis	3.17e-05	0.000275	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ELMO1—primary biliary cirrhosis	3.16e-05	0.000273	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	3.14e-05	0.000271	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	3.11e-05	0.000269	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PDHX—primary biliary cirrhosis	3.1e-05	0.000268	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GGT1—primary biliary cirrhosis	3.09e-05	0.000268	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GOT1—primary biliary cirrhosis	3.09e-05	0.000268	CbGpPWpGaD
Dabrafenib—RAF1—Disease—GOT2—primary biliary cirrhosis	3.05e-05	0.000264	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—NUP210—primary biliary cirrhosis	3.05e-05	0.000264	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CTLA4—primary biliary cirrhosis	3.03e-05	0.000262	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	3.03e-05	0.000262	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	3.03e-05	0.000262	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—MMP2—primary biliary cirrhosis	3.01e-05	0.000261	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CD80—primary biliary cirrhosis	3.01e-05	0.00026	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	3.01e-05	0.00026	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ABCB4—primary biliary cirrhosis	2.91e-05	0.000252	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—DLAT—primary biliary cirrhosis	2.91e-05	0.000252	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—ALB—primary biliary cirrhosis	2.89e-05	0.000251	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD79A—primary biliary cirrhosis	2.89e-05	0.00025	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD80—primary biliary cirrhosis	2.89e-05	0.00025	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TYK2—primary biliary cirrhosis	2.88e-05	0.000249	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—TAB1—primary biliary cirrhosis	2.84e-05	0.000245	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ABCG2—primary biliary cirrhosis	2.83e-05	0.000245	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—NUP210—primary biliary cirrhosis	2.82e-05	0.000244	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PPARGC1A—primary biliary cirrhosis	2.75e-05	0.000238	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—MMP3—primary biliary cirrhosis	2.74e-05	0.000237	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	2.7e-05	0.000234	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.68e-05	0.000232	CbGpPWpGaD
Dabrafenib—BRAF—Disease—HIF1A—primary biliary cirrhosis	2.65e-05	0.000229	CbGpPWpGaD
Dabrafenib—RAF1—Disease—GOT1—primary biliary cirrhosis	2.63e-05	0.000228	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.59e-05	0.000225	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCL5—primary biliary cirrhosis	2.59e-05	0.000224	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	2.58e-05	0.000223	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.57e-05	0.000222	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—TYK2—primary biliary cirrhosis	2.54e-05	0.00022	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	2.54e-05	0.00022	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	2.54e-05	0.00022	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.51e-05	0.000217	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.48e-05	0.000215	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CTGF—primary biliary cirrhosis	2.43e-05	0.00021	CbGpPWpGaD
Dabrafenib—BRAF—Disease—NOS2—primary biliary cirrhosis	2.41e-05	0.000209	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GOT2—primary biliary cirrhosis	2.41e-05	0.000208	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.39e-05	0.000207	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.36e-05	0.000204	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD40LG—primary biliary cirrhosis	2.36e-05	0.000204	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MMP3—primary biliary cirrhosis	2.34e-05	0.000203	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CD80—primary biliary cirrhosis	2.34e-05	0.000202	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—MMP9—primary biliary cirrhosis	2.26e-05	0.000196	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	2.26e-05	0.000196	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CTGF—primary biliary cirrhosis	2.25e-05	0.000195	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—NFKB1—primary biliary cirrhosis	2.24e-05	0.000194	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GOT2—primary biliary cirrhosis	2.23e-05	0.000193	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCL5—primary biliary cirrhosis	2.21e-05	0.000191	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.19e-05	0.000189	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—AGT—primary biliary cirrhosis	2.17e-05	0.000187	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—AGT—primary biliary cirrhosis	2.14e-05	0.000186	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.14e-05	0.000185	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GGT1—primary biliary cirrhosis	2.08e-05	0.00018	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GOT1—primary biliary cirrhosis	2.08e-05	0.00018	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—NFKB1—primary biliary cirrhosis	1.98e-05	0.000171	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TYK2—primary biliary cirrhosis	1.97e-05	0.000171	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GOT1—primary biliary cirrhosis	1.92e-05	0.000167	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GGT1—primary biliary cirrhosis	1.92e-05	0.000167	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.9e-05	0.000164	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.87e-05	0.000161	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.86e-05	0.000161	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.86e-05	0.000161	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.85e-05	0.00016	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—AGT—primary biliary cirrhosis	1.85e-05	0.00016	CbGpPWpGaD
Dabrafenib—RAF1—Disease—HIF1A—primary biliary cirrhosis	1.83e-05	0.000159	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.78e-05	0.000154	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD80—primary biliary cirrhosis	1.75e-05	0.000152	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NUP210—primary biliary cirrhosis	1.75e-05	0.000151	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.71e-05	0.000148	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NOS2—primary biliary cirrhosis	1.67e-05	0.000144	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	1.66e-05	0.000144	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ALB—primary biliary cirrhosis	1.65e-05	0.000142	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CD80—primary biliary cirrhosis	1.64e-05	0.000142	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ABCG2—primary biliary cirrhosis	1.63e-05	0.000141	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MMP3—primary biliary cirrhosis	1.62e-05	0.00014	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—TYK2—primary biliary cirrhosis	1.62e-05	0.00014	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CD80—primary biliary cirrhosis	1.62e-05	0.00014	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	1.56e-05	0.000135	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	1.56e-05	0.000135	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL5—primary biliary cirrhosis	1.53e-05	0.000132	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	1.53e-05	0.000132	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.48e-05	0.000128	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—TYK2—primary biliary cirrhosis	1.48e-05	0.000128	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—AGT—primary biliary cirrhosis	1.44e-05	0.000125	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.43e-05	0.000123	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	1.42e-05	0.000123	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CTGF—primary biliary cirrhosis	1.4e-05	0.000121	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GOT2—primary biliary cirrhosis	1.38e-05	0.00012	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TYK2—primary biliary cirrhosis	1.38e-05	0.00012	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TYK2—primary biliary cirrhosis	1.37e-05	0.000118	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—AGT—primary biliary cirrhosis	1.33e-05	0.000115	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.28e-05	0.000111	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—AGT—primary biliary cirrhosis	1.28e-05	0.000111	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	1.22e-05	0.000105	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	1.21e-05	0.000104	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GOT1—primary biliary cirrhosis	1.19e-05	0.000103	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GGT1—primary biliary cirrhosis	1.19e-05	0.000103	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.18e-05	0.000102	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—NFKB1—primary biliary cirrhosis	1.15e-05	9.97e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CD80—primary biliary cirrhosis	1.13e-05	9.8e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ALB—primary biliary cirrhosis	1.11e-05	9.57e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MMP9—primary biliary cirrhosis	1.09e-05	9.42e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.08e-05	9.32e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPARGC1A—primary biliary cirrhosis	1.06e-05	9.2e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	1.04e-05	9e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	1.04e-05	9e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ALB—primary biliary cirrhosis	1.02e-05	8.86e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TYK2—primary biliary cirrhosis	9.56e-06	8.28e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	9.4e-06	8.13e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	9.26e-06	8.01e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	8.73e-06	7.56e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—AGT—primary biliary cirrhosis	8.28e-06	7.16e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MMP9—primary biliary cirrhosis	7.53e-06	6.52e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	7.49e-06	6.48e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NFKB1—primary biliary cirrhosis	7.45e-06	6.45e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	7.43e-06	6.43e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—AGT—primary biliary cirrhosis	7.21e-06	6.24e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	6.41e-06	5.55e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	6.41e-06	5.55e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALB—primary biliary cirrhosis	6.35e-06	5.5e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	5.71e-06	4.94e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALB—primary biliary cirrhosis	5.54e-06	4.79e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	4.44e-06	3.85e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	3.41e-06	2.95e-05	CbGpPWpGaD
